Beo Therapeutics

Beo therapeutics email format

Verified email-pattern data for Beo Therapeutics is currently limited. You can still use the company insights and contact sections below.
Supplementation with live microbial strains is a novel approach to modulate the synergy between the microbiome and the gastrointestinal system to treat hyperuricemia. A large proportion of the population in the Western world suffers from elevated serum uric acid levels, hyperuricemia. The condition is a causal risk factor for serious diseases such as gout, hypertension, chronic kidney disease and type 2 diabetes. Current standard treatment for hyperuricemia only brings 50% of patients below the recommended treatment target leaving a significant unmet medical need for safe and efficacious treatments. The product will be developed by an innovative combination of a food-supplement development path with pharmaceutical drug development approaches. This accelerates development timelines significantly. The product may be developed for multiple applications as food-supplement, medical food or drug.

Company Details

Employees
3
Founded
-
Address
Zürich, Zürich 8038, Ch
Industry
Pharmaceutical Manufacturing
Keywords
LyteGro.
HQ
Zürich, Zürich
Looking for a particular Beo Therapeutics employee's phone or email?

Beo Therapeutics Questions

Top Beo Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant